In in vivo solid tumor models (breast, gastric and ovarian cancers), it was shown that CCL2/CCR2 axis mediated the migration of MSC into the tumor and also showed evidence of CCL2-mediated protumor effect. The gene discussed is CCL2; the disease is ovarian carcinoma.